Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1545-1547

  Carlomagno, Guido ^a   Messalli, Giancarlo ^a   Melillo, Rosa Marina ^a   Stanziola, Anna Agnese ^a   Visciano, Carla ^a   Mercurio, Valentina ^a   Imbriaco, Massimo ^a   Ghio, Stefano ^b   Sofia, Matteo ^a   Bonaduce, Domenico ^a   Fazio, Serafino ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Biomarkers; Cardiac magnetic resonance; Pulmonary arterial hypertension; Right ventricular function; ST2

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 33; SOLUBLE ST2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART CATHETERIZATION; HEART DILATATION; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE REMODELING; HEART VENTRICLE SIZE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; SYSTOLIC DYSFUNCTION;

6-MINUTE WALKING DISTANCE; 6MWD; BIOMARKERS; CARDIAC MAGNETIC RESONANCE; CARDIAC MAGNETIC RESONANCE IMAGING; CHF; CHRONIC LEFT-SIDED HEART FAILURE; CMR; IL-33; INTERLEUKIN 33; N-TERMINAL FRAGMENT OF PRO-B-TYPE NATRIURETIC PEPTIDE; NT-PROBNP; PAH; PULMONARY ARTERIAL HYPERTENSION; PULMONARY VASCULAR RESISTANCE; PVR; RHC; RIGHT HEART CATHETERIZATION; RIGHT VENTRICLE; RIGHT VENTRICULAR EJECTION FRACTION; RIGHT VENTRICULAR END-DIASTOLIC VOLUME INDEX; RIGHT VENTRICULAR END-SYSTOLIC VOLUME INDEX; RIGHT VENTRICULAR FUNCTION; RV; RVEDVI; RVEF; RVESVI; SOLUBLE ST2; SST2; ST2;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INTERLEUKINS; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE;

EID: 84885332046     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.031     Document Type: Article

References (9)

1. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC), European Respiratory Society (ERS), International Society of Heart and Lung Transplantation (iSHLT), et al. Guidelines for the diagnosis and treatment of pulmonary Hypertension. Eur Respir J 2009;34:1219-63.
2. Bradlow WM, Gibbs JS, Mohiaddin RH. Cardiovascular magnetic resonance In pulmonary Hypertension. J Cardiovasc Magn Reson 2012;14:6.
3. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically Induced and cardioprotective signaling system. J Clin Invest 2007;117:1538-49.
4. Daniels LB, Clopton P, Iqbal N, Tran K, Maisel AS. Association of ST2 levels with cardiac structure and function and mortality In outpatients. Am Heart J 2010;160:721-85.
5. Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Serum levels of the Interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality In patients with acute dyspnea. Circ Heart Fail 2009;2:311-9.
6. Drake Ji, Bogaard HJ, Mizuno S, et al. Molecular signature of a right heart failure program In chronic severe pulmonary Hypertension. Am J Respir Cell Mol Biol 2011;45:1239-47.
7. Bartunek J, Delrue L, Van Durme F, et al. Nonmyocardial production of ST2 protein In human hypertrophy and failure Is related to diastolic load. J Am Coll Cardiol 2008;52:2166-74.
8. Ky B, French B, McCloskey K, et al. high-sensitivity ST2 for prediction of adverse outcomes In chronic heart failure. Circ Heart Fail 2011;4:180-7.
9. vanWolferen SA,Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function In Idiopathic pulmonary arterial Hypertension. Eur Heart J 2007;28:1250-7.